SCHEMBL7961776

SCHEMBL7961776

O=C1CCN(c2ccc3scnc3c2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OGA O60502 4/20 0.47
MMP2 P08253 1/20 0.44
ADAMTS5 Q9UNA0 1/20 0.44
LMNA P02545 1/20 0.41
CYP3A4 P08684 1/20 0.41
GAA P10253 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTT P42858 1/20 0.41
FASN P49327 1/20 0.39
CRBN Q96SW2 5/20 0.39
GRM1 Q13255 2/20 0.38
GRM5 P41594 1/20 0.38
MAP3K11 Q16584 1/20 0.38
DDB1 Q16531 3/20 0.37
ALDH1A1 P00352 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TRPA1 O75762 1/20 0.37
IP6K1 Q92551 1/20 0.36
IP6K3 Q96PC2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15548204 0.80 ADRB1 (0.46) OGAMMP2ADAMTS5CYP3A4CYP2C9
SCHEMBL30609653 0.80 ADRB1 (0.46) OGAMMP2ADAMTS5CYP3A4CYP2C9
SCHEMBL23075831 0.78 MMP2 (0.45) OGAMMP2ADAMTS5LMNACYP3A4
SCHEMBL5798538 0.76 PDE3B (0.46) OGAMMP2ADAMTS5LMNACYP3A4
SCHEMBL17543290 0.74 MEN1 (0.63) OGALMNAGAAIP6K1IP6K3
SCHEMBL21091414 0.74 GAA (0.57) OGALMNACYP3A4GAACYP2C9
SCHEMBL7961838 0.74 DRD3 (0.47) OGALMNAGAAHTTALDH1A1
SCHEMBL28983139 0.73 MMP2 (0.46) OGAMMP2ADAMTS5LMNACYP3A4
SCHEMBL30410568 0.73 MMP2 (0.46) OGAMMP2ADAMTS5LMNACYP3A4
SCHEMBL23075769 0.71 CRBN (0.64) MMP2ADAMTS5CRBNDDB1SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1342074-A Antidepressant heterocyclic compounds BRISTOL MYERS SQUIBB CO (US) 2002-03-27 CN disclosed
US-6225324-B1 POTENT INHIBITION OF 5-HT REUPTAKE; 1,3-DISUBSTITUTED PYRROLIDINE, 1,4-DISUBSTITUTED PIPERIDINE, OR 1,4-DISUBSTITUTED HEXAHYDROAZEPINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY 2001-05-01 US disclosed